Evaluation of N parameter in the staging of non-small cell lung cancer: Role of CT and PET;Valutazione del parametro N nella stadiazione dei tumori polmonari non a piccole cellule: Ruolo di TC e PET

Radiologia Medica

Volumn 109, Issue 5-6, 2005, Pages 449-459

  Spaggiari, Lucia ^a   Sverzellati, Nicola ^a   Versari, Annibale ^b   Paci, Massimiliano ^b   Ferrari, Guglielmo ^b   Nicoli, Franco ^b   Zompatori, Maurizio ^a,c  

^a UNIVERSITY OF PARMA   (Italy)

^b Azienda Ospedaliera Arcisp S M   (Italy)

^c Ospedale Easori   (Italy)

Author keywords

Computed tomography; Lung neoplasms, staging; PET

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 33744492195     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Negri E, La Vecchia C, Decarli A: Cancer mortality in Italy, 1998. Tumori 88: 89-94, 2002.
2. Gupta C, Tamin WJ, Graeber GG et al: Mediastinal lymph node sampling following Positron Emission Tomography with Fluorodeoxyglucose imaging in lung cancer staging. Chest 120: 521-527, 2001.
3. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 111: 1711-1717, 1997.
4. Okada M, Tsubota N, Yoshimura M et al. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations. Chest 118: 123-128, 2000.
5. Mouroux J, Venissac N, Alifano M: Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer. Ann Thorac Surg 72: 1698-1704, 2001.
6. Toloza EM, Harpole L, Detterbeck F et al: Invasive staging of non-small cell lung cancer. Chest 123: 157S-166S, 2003.
7. Antoch G, Stattaus J, Nemat AT et al: Non-small cell lung cancer: dual modality PET/CT in preoperative staging. Radiology 229: 526-533, 2003.
8. Scott WJ, Gobar LS, Terry JD et al: Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computer tomography and positron emission tomography. Thorac Cardiovasc Surg 111: 642-648, 1996.
9. Kelly RF, Tran T, Holmstrom A et al: Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest 125: 1413-1423, 2004.
10. Pieterman RM, Van Putten JWG et al: Preoperative staging of non-small cell lung cancer with positron emission tomography. N Engl J Med 343: 254-261, 2000.
11. Dwamena BA, Sonnad SS, Angobaldo JO et al: Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology 213: 530-536, 1999.
12. Muller NL, Fraser RS, Colman NC et al: Diagnostica per immagini delle malattie del torace. In: Neoplasie polmonari, pag 215-259, Quarta edizione. Verducci editore, Roma, 2003.
13. Gross BH, Glazer GM, Orringer MB et al: Bronchogenic carcinoma metastatic to normal sized lymph nodes: frequency and significance. Radiology 166: 71-74, 1998.
14. Arita T, Kuramitsu T, Kawamura M et al: Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 50: 1267-1271, 1995.
15. Whittlesey D: Prospective computed tomographic scanning in the staging of bronchogenic cancer. J Thorac Cardiovasc Surg 95: 876-882, 1998.
16. McLoud TC, Bourgouin PM, Greenberg RW et al: Bronchogenic carcinoma: analysis of staging in mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182: 319-323, 1992.
17. Seely JM, Mayo JR, Miller RR et al: T1 lung cancer: prevalence of mediastinal node metastases and diagnostic accuracy of CT. Radiology 186: 129-132, 1993.
18. Buy JN, Ghossian MA, Poirson F et al: Computed tomography of mediastinal lymph nodes in nonsmall cell lung cancer: a new approach based on the lymphatic pathway of tumor spread. J Comput Assist Tomogr 12: 545-552, 1988.
19. Ikezoe J, Kadowaki K, Morimoto S et al: Mediastinal lymph node metastases from non-small cell bronchogenic carcinoma: revaluation with CT. JCAT 14: 360-367, 1990.
20. McLoud TC, Swenson SJ: Lung carcinoma. Clin Chest Med 20: 697-713, 1999.
21. Patz EF JR. Erasmus JJ, McAdams MP et al: Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thotax. Radiology 212: 56-60, 1999.
22. Vertagen AF, Bootsma GP, Tjan-Heijnen VC et al: FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 44: 175-181, 2004.
23. Cerfolio PJ, Ojha B, Bryant AS et al: The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 76: 861-866, 2003.
24. Fritscher-Ravens A: Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography and endoscopic ultrasonography with and without fine needle-aspiration. Chest 123: 442-453, 2003.
25. Mezzetti M, Calati AM, Schubert L: La scintigrafia ad emissione di positroni nella diagnosi e stadiazione del carcinoma polmonare: la nostra esperienza. Min Chir 57: 461-465, 2002.
26. Kernstine KH, McLaughlin KA et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer?. Ann Thorac Surg 73: 394-402, 2002.